| Serial Number | 88807844 |
| Word Mark | RED CELL THERAPEUTICS |
| Filing Date | Monday, February 24, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 19, 2021 |
| Registration Number | 6532454 |
| Registration Date | Tuesday, October 19, 2021 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Disclaimer with Predetermined Text | "CELL THERAPEUTICS" |
| Goods and Services | Cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; pharmaceutical preparations of engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; engineered erythroid cells for medical or clinical use for the treatment of a variety of human diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders; none of the foregoing used as vitamin-mineral supplements or for animals |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 27, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, November 11, 2020 |
| First Use In Commerce Date | Wednesday, November 11, 2020 |
| Party Name | Rubius Therapeutics, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Party Name | Rubius Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
| Event Date | Event Description |
| Tuesday, October 19, 2021 | REGISTERED-SUPPLEMENTAL REGISTER |
| Wednesday, September 15, 2021 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Tuesday, September 7, 2021 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Tuesday, September 7, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, September 7, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 7, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, September 7, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, July 21, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, July 20, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 20, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 9, 2021 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
| Saturday, February 6, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, February 6, 2021 | NON-FINAL ACTION E-MAILED |
| Saturday, February 6, 2021 | NON-FINAL ACTION WRITTEN |
| Saturday, February 6, 2021 | USE AMENDMENT ACCEPTED |
| Tuesday, January 12, 2021 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, November 19, 2020 | USE AMENDMENT FILED |
| Friday, November 20, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 19, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 19, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 19, 2020 | TEAS AMENDMENT OF USE RECEIVED |
| Wednesday, May 20, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 20, 2020 | NON-FINAL ACTION E-MAILED |
| Wednesday, May 20, 2020 | NON-FINAL ACTION WRITTEN |
| Wednesday, May 13, 2020 | ASSIGNED TO EXAMINER |
| Saturday, March 21, 2020 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Friday, March 13, 2020 | ASSIGNED TO LIE |
| Friday, March 6, 2020 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Thursday, February 27, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, February 27, 2020 | NEW APPLICATION ENTERED IN TRAM |